How we handle sensitive health content
Information about medication and weight can change real decisions, so we hold our content to a careful, transparent standard. Here is the stance we hold ourselves to.
Educational only, not medical advice
Everything GLP-Done publishes is educational. It is not medical advice, and it does not replace the judgment of your own clinician. Please talk to a qualified healthcare professional before starting, stopping, changing, or tapering any medication. Your situation, history, and goals are specific to you, and only someone who knows them can advise you safely.
We never instruct on dosing
We will never tell you how much of a medication to take, when to take it, or how to adjust it. Dosing is the clinician's job, full stop. We can explain how a class of medication generally works and what the research describes, but the specific numbers and the timing of any change belong in the conversation between you and your prescriber.
No efficacy guarantees
Bodies vary, and so do outcomes. We use ranges and caveats, and we do not promise results. You will not see us say a strategy is “guaranteed” or that it “prevents regain.” Instead we describe what the evidence suggests, for whom, and with what uncertainty, so you can set realistic expectations.
- We report likely ranges, not fixed outcomes.
- We avoid absolute language like guaranteed or prevents.
- We name individual variation rather than hiding it.
Obesity is a chronic condition
We frame obesity as a chronic condition, because that is what the medical consensus supports. Weight regain after a GLP-1 is physiology, a body responding the way bodies are built to respond, not a personal failure or a lack of willpower. Our language is meant to be identity-affirming and non-shaming. You will not find “cheat days” here, and you will not find before-and-after shaming. The aim is to be on your side, plainly and consistently.
Conflict-of-interest statement
GLP-Done receives no compensation from drug manufacturers. We are not paid to feature, recommend, or rank any medication or brand, and our content is educational rather than promotional. If that ever changes, we will disclose it clearly and prominently.
Authorship transparency
Content is created and maintained by Ian MacCallum, the founder. We do not fabricate clinician credentials, and we do not apply a “medically reviewed by” label we have not earned. We will only attach a named reviewer when a credentialed clinician is genuinely engaged to review the work. Until then, we would rather be honest about who is behind the words. You can read more about our sourcing in our methodology and about our team on the authors page.
Correction policy
We get things wrong sometimes, and when we do we want to fix them in the open. Errors are corrected promptly, with a visible note in the article's update log describing what changed. If you spot something that looks inaccurate, please tell us at iancmaccallum@gmail.com and we will look into it.
Why compliance is load-bearing here
This is not abstract caution. The FDA has taken enforcement action against false and misleading GLP-1 marketing, which is part of why we treat accuracy and restraint as non-negotiable. Holding to these standards protects you as a reader, and it keeps our content honest about what these medications can and cannot do.